NAVPREET KAUR: Open Payments
NPI 1982141511 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 15 payments from 9 companies in 2025. Trend: 2023 $219 · 2024 $257 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $77 |
| Novo Nordisk Inc | 3 | $72 |
| GlaxoSmithKline, LLC. | 2 | $63 |
| Lilly USA, LLC | 2 | $46 |
| Medtronic, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $33 |
| Amgen Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, Rybelsus, MINIMED 780G, UBRELVY, JARDIANCE, Ozempic, OTEZLA.
Industry payments across CA — which companies pay providers there.
